Has Moshe Levy received payments from drug or device companies?

Yes. Drug and device makers reported $7,570 in general payments to Moshe Levy across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Moshe Levy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Moshe Levy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Moshe Levy

Pediatrics · Manalapan, NJNPI 1205860889

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,525 of the $7,570 with a category attached, or 86.2%. AbbVie accounts for 85.9% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $5,861, more than ten times the $104 reported in 2019. Among pediatrics clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,570in general payments, 2019–2025

Across 40 payments — averaging $189.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$6K
Sanofi$329
Baxter Healthcare$200
Supernus Pharmaceuticals, Inc.$153
Kaleo, Inc.$76
Takeda Pharmaceuticals U.S.A., Inc.$42
plus $270 from 13 others

$16,446in research payments, 2019–2025

Across 5 payments — averaging $3289.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Gilead$13K
Amgen$3K
Novartis$1K

What the payments were for

Consulting fees$6,52586%
Travel & lodging$1742%
Food & beverage$87112%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	4	$6,499
Sanofi	6	$329
Baxter Healthcare	1	$200
Supernus Pharmaceuticals, Inc.	3	$153
Kaleo, Inc.	6	$76
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Genentech USA, Inc.	3	$38
Phadia US Inc.	2	$36
Adlon Therapeutics L.p.	2	$30
Sanofi Pasteur Inc.	2	$28
GSK	1	$22
Lilly USA, LLC	1	$18
Meridian Bioscience Inc.	1	$18
UCB, Inc.	1	$17
Pfizer	1	$15
Ironshore Pharmaceuticals Inc.	1	$13
Merck	1	$12
AstraZeneca	1	$12
Novartis	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,570 in reported general payments places this provider in the 95th percentile of 1,890 pediatrics providers in New Jersey.

See all pediatrics providers in New Jersey →

Other pediatrics in Manalapan

Steven MateretskyHackensack$290K
Sara RaymondMorristown$288K
Andrew MulbergCamden$264K
Bram GreenbergLakewood$200K
David ApelianBoonton$149K
Christopher AmatoGibbsboro$34K
Syeda Amna HusainMarlboro$27K
Nika DouvikasJersey City$27K
Melanie DegliuominiHackensack$17K
Alexandra LaurenzanoRiver Vale$15K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →